HOME >> MEDICINE >> NEWS
Many low income Medicare beneficiaries will still face high drug bills under proposals in Congress

one-fifth of their income on drugs. This couple would see their out-of-pocket drug costs reduced to 4.1 percent of income under the House bill, and 3.4 percent under the Senate bill. While both bills provide substantial subsidies for beneficiaries at 130 percent of poverty, subsidies are phased out at slightly higher income levels. A couple at 160 percent of poverty ($20,944), still a very modest income, would pay $2,437, or 11.6 percent of their income, on prescription drugs under the House bill, and $3,208, or 15.3 percent of their income, under the Senate bill. Although this coverage is an improvement, spending between 10 and 15 percent of personal income on drugs still represents a significant financial hardship, especially in light of out-of-pocket expenses for other services, Part B premiums, and supplemental health insurance premiums.

About 10.2 million elderly and disabled Medicare beneficiaries fall in the $10,000$20,000 income bracket. Beneficiaries in this near-poor group spend more out-of-pocket on prescription drugs than those in other income groups, despite the fact that their total drug spending is lower on average. More than one-fourth (27%) of the near-poor spent 5 percent or more of their income on out-of-pocket drug costs in 1999, while nearly one of eight (12%) spent 10 percent or more of their incomes on out-of-pocket costs for drugs.

The near-poor's out-of-pocket drug spending increased 37 percent from 1993 to 1999. More so than other income groups, they depend on private Medicare+Choice plans for their drug coverage--a highly unstable source of coverage in recent years due to plan withdrawals, rising cost-sharing, and shrinking benefits.


'"/>

Contact: Mary Mahon
mm@cmwf.org
212-606-3853
Commonwealth Fund
15-Aug-2003


Page: 1 2

Related medicine news :

1. Prevalence of overweight increasing in young children from low-income families
2. People with low incomes more likely to develop brain tumors
3. Low-income Native American women suffer high rates of domestic abuse
4. Families working together improves diabetes management for low income kids, study finds
5. Effect of diabetes case management among low-income minority populations
6. Familys income, education affect depression and obesity in teens
7. Breast cancer program for low-income women suggests importance of access to screening
8. Work stress can affect how lower-income families eat
9. Aggressive exercise program helps inner city, low-income disabled
10. Ten schools receive funds to improve access to dental care, enroll minority/low income students
11. Physical, mental health illnesses hinder low-income families economic security

Post Your Comments:
(Date:6/17/2013)... (PRWEB) June 17, 2013 Dallas-based physician ... the nation to offer the hybrid concierge model from ... model to offer her patients a wider variety of ... and a greater emphasis on prevention and wellness had ... who want a concierge-style of medicine, but doesn't force ...
(Date:6/17/2013)... Stem Cell Institute (HSCI) researchers have identified in the ... regulate embryonic stem cell self-renewal, beginning a creative search ... The gene, SALL4, gives stem cells their ability to ... cells. Typically, cells only express SALL4 during embryonic development, ... of acute myeloid leukemia and 10 to 30 percent ...
(Date:6/17/2013)... San Antonio Eye Center PA has been growing a lot recently. ... a new portion of the office, the optical shop. Their loyal ... years, and SA Eye Center has delivered. , The new ... providing patients with everything they need in regards to eye care, ... the largest SA Eye Center in the city. The shop ...
(Date:6/17/2013)... 17, 2013) A team from the New York ... Berrie Diabetes Center of Columbia University has generated patient-specific ... features of maturity-onset diabetes of the young (MODY). ... to produce induced pluripotent stem (iPS) cells, from which ... the stem cell-derived beta cells secreted insulin in a ...
(Date:6/17/2013)... June 17, 2013 The Professional ... that they are now open in Schertz. ... treatments, counseling and access to educational support groups. ... be used to help with athletic performance, post ... the center, Cheryl Camarillo, LCSW, works primarily with ...
Breaking Medicine News(10 mins):Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3Health News:A new target for cancer drug development 2Health News:San Antonio Eye Center PA Opens New Optical Shop 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Professional Center for Enhanced Performance Opens in Schertz 2
(Date:6/17/2013)... 17, 2013  CureMD and Mitochon Systems Inc., announced ... CureMD will become the exclusive provider of SMART Cloud ... user base. (Logo: http://photos.prnewswire.com/prnh/20130617/PH32637LOGO ) ... to Mitochon users as they will be able to ... affordable price," said Bill Hashmat , CIO at ...
(Date:6/17/2013)... NORTH CHICAGO, Ill. , June 17, 2013 ... announced preliminary results from a Phase I study ... selective inhibitor, in patients with high-risk relapsed/refractory chronic ... non-Hodgkin,s lymphoma (NHL). High-risk CLL patients are those ... is refractory to fludarabine therapy. These data were ...
(Date:6/17/2013)... 17, 2013 Sanofi Pasteur, the vaccines division ... ), announced today the launch of Headfirst! Expert ... expand understanding of head lice infestation and how to ... time or managing a recurrent or persistent infestation may ... experts in the fields of parenting, education and medicine ...
Breaking Medicine Technology:CureMD Becomes the Exclusive Provider of 4,400 Mitochon Free EMR Users 2AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 2AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 3AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 4AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 5AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 6Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 2Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 3Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 4Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 5Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 6
Cached News: